litlas
ログインアカウント作成

Sylvie Négrier

1989–2025 年に発表

別表記
Sylvie Negrier
83
論文数
30,976
被引用数
59
h 指数
81
i10 指数

被引用数

Sylvie Négrier の年別被引用数1956 年: 被引用 3 件1990 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 5 件1993 年: 被引用 9 件1994 年: 被引用 8 件1995 年: 被引用 14 件1996 年: 被引用 7 件1997 年: 被引用 15 件1998 年: 被引用 29 件1999 年: 被引用 39 件2000 年: 被引用 40 件2001 年: 被引用 39 件2002 年: 被引用 44 件2003 年: 被引用 54 件2004 年: 被引用 50 件2005 年: 被引用 65 件2006 年: 被引用 64 件2007 年: 被引用 171 件2008 年: 被引用 271 件2009 年: 被引用 347 件2010 年: 被引用 340 件2011 年: 被引用 336 件2012 年: 被引用 333 件2013 年: 被引用 362 件2014 年: 被引用 263 件2015 年: 被引用 229 件2016 年: 被引用 222 件2017 年: 被引用 201 件2018 年: 被引用 193 件2019 年: 被引用 725 件2020 年: 被引用 845 件2021 年: 被引用 645 件2022 年: 被引用 467 件2023 年: 被引用 356 件2024 年: 被引用 471 件2025 年: 被引用 178 件2026 年: 被引用 10 件1957〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,339 件、この内訳の 27.1%中国: 引用元論文 694 件、この内訳の 8%フランス: 引用元論文 647 件、この内訳の 7.5%イタリア: 引用元論文 543 件、この内訳の 6.3%イギリス: 引用元論文 507 件、この内訳の 5.9%ドイツ: 引用元論文 404 件、この内訳の 4.7%日本: 引用元論文 331 件、この内訳の 3.8%カナダ: 引用元論文 311 件、この内訳の 3.6%オランダ: 引用元論文 262 件、この内訳の 3%スペイン: 引用元論文 260 件、この内訳の 3%オーストラリア: 引用元論文 198 件、この内訳の 2.3%ベルギー: 引用元論文 176 件、この内訳の 2%
0%27.1%その他 22.8%

機関

分野

  • Medicine73.7%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Immunology and Microbiology6.1%
  • Mathematics0.7%
  • Computer Science0.6%
  • Engineering0.5%
  • その他2.1%

トピック

  • Renal cell carcinoma treatment11.7%
  • Cancer Immunotherapy and Biomarkers9%
  • Immunotherapy and Immune Responses3.4%
  • Renal and related cancers3.4%
  • CAR-T cell therapy research2.9%
  • Angiogenesis and VEGF in Cancer2.9%
  • その他66.7%

共著者

全論文

検索で開く
  1. Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

    著者: Robert J. Motzer, Konstantin Penkov, John B.A.G. Haanen, Brian I. Rini, Laurence Albigès, Matthew T. Campbell, Balaji Venugopal, Christian Kollmannsberger, Sylvie Négrier, Motohide Uemura, Jae L. Lee, Aleksandr Vasiliev, Wilson H. Miller, Howard Gurney, Manuela Schmidinger, James Larkin, Michael B. Atkins, Jens Bedke, B. Yа. Alekseev, Jing Wang, Mariangela Mariani, Paul B. Robbins, Aleksander Chudnovsky, Camilla Fowst, Subramanian Hariharan, Bo Huang, Alessandra di Pietro, Toni K. Choueiri - New England Journal of Medicine 2019 被引用: 2,550

  2. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

    著者: Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Négrier, Cezary Szczylik, Sindy T. Kim, Isan Chen, Paul Bycott, Charles M. Baum, Robert A. Figlin - New England Journal of Medicine 2007 被引用: 5,756

  3. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

    著者: Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Siebels, Sylvie Négrier, Christine Chevreau, E Solska, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sara M. Freeman, Brian Schwartz, Minghua Shan, Ronit Simantov, Ronald M. Bukowski - New England Journal of Medicine 2007 被引用: 4,784

  4. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

    著者: Jedd D. Wolchok, Bart Neyns, Gerald P. Linette, Sylvie Négrier, Jose Lutzky, L. Thomas, William Waterfield, Dirk Schadendorf, Michael Smylie, Troy H. Guthrie, Jean‐Jacques Grob, Jason Chesney, Kevin M. Chin, Kun Chen, Axel Hoos, Steven O’Day, Célèste Lebbé - The Lancet Oncology 2009 被引用: 1,187

  5. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

    著者: Brian I. Rini, Bernard Escudier, Piotr Tomczak, А. Д. Каприн, Cezary Szczylik, Thomas E. Hutson, M. Dror Michaelson, В. А. Горбунова, Martin Gore, И. Г. Русаков, Sylvie Négrier, Yen-Chuan Ou, Daniel Castellano, Ho Yeong Lim, Hirotsugu Uemura, Jamal Tarazi, David Cella, Connie Chen, Brad Rosbrook, Sinil Kim, Robert J. Motzer - The Lancet 2011 被引用: 1,849

  6. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

    著者: Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Stéphane Oudard, Sylvie Négrier, Cezary Szczylik, Роберто Пили, Georg A. Bjarnason, Xavier García del Muro, Jeffrey A. Sosman, E Solska, George Wilding, John A. Thompson, Sindy T. Kim, Isan Chen, Xin Huang, Robert A. Figlin - Journal of Clinical Oncology 2009 被引用: 2,189

  7. Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

    著者: Robert J. Motzer, Bernard Escudier, Piotr Tomczak, Thomas E. Hutson, M. Dror Michaelson, Sylvie Négrier, Stéphane Oudard, Martin Gore, Jamal Tarazi, Subramanian Hariharan, Connie Chen, Brad Rosbrook, Sinil Kim, Brian I. Rini - The Lancet Oncology 2013 被引用: 745

  8. Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

    著者: Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt, Frédéric Rolland, Irène Philip, Céline Galéa, Samuel Salot, Soraya Saïagh, Marie Audrain, Marie Rimbert, Sylvie Lafaye-de Micheaux, Jérôme Tiollier, Sylvie Négrier - Cancer Immunology Immunotherapy 2008 被引用: 239

  9. Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

    著者: Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard, Michael Staehler, Sylvie Négrier, Christine Chevreau, Apurva A. Desai, Frédéric Rolland, Tomasz Demkow, Thomas E. Hutson, Martin Gore, Sibyl Anderson, Gloria Hofilena, Minghua Shan, Carol Peña, Chetan Lathia, Ronald M. Bukowski - Journal of Clinical Oncology 2009 被引用: 1,083

  10. Uveal melanoma: In the era of new treatments

    著者: Mylène Wespiser, Eve‐Marie Neidhardt, Sylvie Négrier - Cancer Treatment Reviews 2023 被引用: 49

  11. Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

    著者: Ronan Flippot, Cécile Dalban, Brigitte Laguerre, Delphine Borchiellini, Gwénaëlle Gravis, Sylvie Négrier, Christine Chevreau, Florence Joly, Lionnel Geoffrois, Sylvain Ladoire, Hakim Mahammedi, Frédéric Rolland, Marine Gross‐Goupil, Élise Deluche, Frank Priou, Mathieu Laramas, Philippe Barthélémy, Bérengère Narciso, Nadine Houédé, Stéphane Culine, Stéphane Oudard, Marina Chenot, Florence Tantot, Sylvie Chabaud, Bernard Escudier, Laurence Albigès - Journal of Clinical Oncology 2019 被引用: 163

  12. TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma

    著者: Laurence Albigès, Philippe Barthélémy, Marine Gross‐Goupil, Sylvie Négrier, Michael N. Needle, Bernard Escudier - Annals of Oncology 2020 被引用: 57

  13. A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

    著者: J-F Rossi, Sylvie Négrier, Nicholas D. James, Ivo Kocák, Robert D. Hawkins, Hugh M. Davis, Uma Prabhakar, Xiang Qin, Peter F.A. Mulders, Birge Berns - British Journal of Cancer 2010 被引用: 188

  14. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial

    著者: Serge Leyvraz, Sophie Piperno‐Neumann, Stefan Suciu, J.F. Baurain, Marcin Zdzienicki, Alessandro Testori, Ernest Marshall, M. E. Scheulen, Thomas Jouary, Sylvie Négrier, Jan B. Vermorken, Eckhart Kaempgen, Xavier Durando, Dirk Schadendorf, Ravichandra Karra Gurunath, Ulrich Keilholz - Annals of Oncology 2014 被引用: 147

  15. Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

    著者: Christopher Montemagno, Anaïs Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Iovanna, Nathalie Rioux-Leclercq, Camillo Porta, Sylvie Négrier, Jean-­Marc Ferrero, Emmanuel Chamorey, Gilles Pagès, Maeva Dufies - OncoImmunology 2020 被引用: 66

  16. Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas

    著者: Jonathan Thouvenin, Omar Alhalabi, Maria I. Carlo, Lucía Carril-Ajuria, Laure Hirsch, Nieves Martínez Chanzá, Sylvie Négrier, Luca Campedel, Dylan J. Martini, Delphine Borchiellini, Jad Chahoud, Massimo Lodi, Philippe Barthélémy, Elshad Hasanov, Andrew W. Hahn, Thierry Gil, Srinivas R. Viswanathan, Ziad Bakouny, Pavlos Msaouel, Mehmet Asım Bilen, Toni K. Choueiri, Laurence Albigès, Nizar M. Tannir, Gabriel G. Malouf - The Oncologist 2022 被引用: 37

  17. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

    著者: Sylvie Négrier, Bernard Escudier, Christine Lasset, Jean‐Yves Douillard, J. Savary, Christine Chevreau, Alain Ravaud, A. Mercatello, J Pény, Mireille Mousseau, Thierry Philip, Thomas Tursz - New England Journal of Medicine 1998 被引用: 969

  18. Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis

    著者: Bernard Escudier, Vincent Molinié, Sergio Bracarda, Pablo Maroto, Cezary Szczylik, Paul Nathan, Sylvie Négrier, Claudia Weiß, Camillo Porta, Viktor Grünwald, Laurence Albigès - European Journal of Cancer 2016 被引用: 92

  19. Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression

    著者: Lindsay S. Cooley, Justine Rudewicz, Wilfried Souleyreau, Andrea Emanuelli, Arturo Álvarez-Arenas, Kim Clarke, Francesco Falciani, Maeva Dufies, Diether Lambrechts, Elodie Modave, Domitille Chalopin-Fillot, Raphaël Pineau, Damien Ambrosetti, Jean‐Christophe Bernhard, Alain Ravaud, Sylvie Négrier, Jean-­Marc Ferrero, Gilles Pagès, Sébastien Benzekry, Macha Nikolski, Andréas Bikfalvi - Molecular Cancer 2021 被引用: 55

  20. Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

    著者: Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, Yann Vano, Luca Campedel, Elshad Hasanov, Ziad Bakouny, Andrew W. Hahn, Mehmet Asım Bilen, Pavlos Msaouel, Toni K. Choueiri, Srinivas R. Viswanathan, Kanishka Sircar, Laurence Albigès, Gabriel G. Malouf, Nizar M. Tannir - The Oncologist 2023 被引用: 36

  21. Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival

    著者: Bernard Escudier, Joaquim Bellmunt, Sylvie Négrier, Emilio Bajetta, Bohuslav Melichar, Sergio Bracarda, Alain Ravaud, Sophie Golding, Sangeeta Jethwa, Vesna Šneller - Journal of Clinical Oncology 2010 被引用: 808

  22. The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

    著者: Renaud Grépin, Mélanie Guyot, Sandy Giuliano, Marina Boncompagni, Damien Ambrosetti, Emmanuel Chamorey, Jean‐Yves Scoazec, Sylvie Négrier, Hélène Simonnet, Gilles Pagès - Cancer Research 2013 被引用: 124

  23. Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

    著者: Toni K. Choueiri, Konstantin Penkov, Hiroji Uemura, Matthew T. Campbell, Sumanta K. Pal, Christian Kollmannsberger, J.L. Lee, B. Venugopal, A.J.M. van den Eertwegh, Sylvie Négrier, Howard Gurney, Laurence Albigès, Raanan Berger, John B.A.G. Haanen, Víctor Manuel Oyervides-Juárez, Brian I. Rini, James Larkin, Franco Nolè, M. Schmidinger, M.B. Atkins, Yoshihiko Tomita, B. Ellers-Lenz, Jason Hoffman, R. Sandner, J. Wang, A. di Pietro, R.J. Motzer - Annals of Oncology 2024 被引用: 49

  24. Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

    著者: Philippe Rougier, R. Bugat, Jean‐Yves Douillard, Stéphane Culine, Etienne Suc, Pierre Brunet, Y. Bécouarn, Marc Ychou, M. Marty, Jean Marc Extra, Jacques Bonneterre, Antoine Adenis, Jean‐François Seitz, G. Ganem, M. Namer, Thierry Conroy, Sylvie Négrier, Yacine Merrouche, F Bürki, M Mousseau, Patrice Herait, Mondher Mahjoubi - Journal of Clinical Oncology 1997 被引用: 433